Notes
2015 US dollars
Reference
Mann M, et al. Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis. Drug Safety : 17 Jun 2016. Available from: URL: http://doi.org/10.1007/s40264-016-0432-y
Rights and permissions
About this article
Cite this article
Active surveillance cost effective for first-line HAART in Namibia. PharmacoEcon Outcomes News 756, 9 (2016). https://doi.org/10.1007/s40274-016-3158-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3158-2